SCHEMBL12021925

SCHEMBL12021925

Cc1ccnc(-c2ccc(F)c(S)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.34
S1PR1 P21453 1/20 0.34
IRAK4 Q9NWZ3 2/20 0.34
KMO O15229 2/20 0.33
DYRK1A Q13627 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
TGFBR1 P36897 1/20 0.33
RXRA P19793 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
MPL P40238 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2666284 0.83 MEN1 (0.40) MEN1KMT2ANPC1RAB9AATM
SCHEMBL10864552 0.81 IRAK4 (0.39) MEN1KMT2ANPC1RAB9AS1PR1
SCHEMBL2666270 0.81 KMO (0.47) MEN1KMT2AKMODYRK1ACLK4
SCHEMBL8282000 0.81 HSD17B10 (0.46) MEN1KMT2ANPC1RAB9AATM
SCHEMBL8226435 0.81 RXRA (0.44) MEN1KMT2ANPC1RAB9AATM
SCHEMBL8221626 0.78 GRIN2B (0.35) MEN1KMT2ANPC1RAB9AATM
SCHEMBL22130225 0.77 KIT (0.41) MEN1KMT2ANPC1RAB9AATM
SCHEMBL22578238 0.77 CYP1A2 (0.47) MEN1KMT2ANPC1RAB9AATM
SCHEMBL2666243 0.77 KMO (0.47) KMODYRK1ACLK4
SCHEMBL31533414 0.77 CYP17A1 (0.46) MEN1KMT2ANPC1RAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934227-B1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORP (US) 2011-12-21 EP disclosed
WO-2007035542-A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2007-03-29 WO disclosed